Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06197165

Amylo-Shiatsu-Acute-Chronic: Effects of Shiatsu on Symptoms and Quality of Life of Amyloidosis Patients

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-01-15

108

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the effects of targeted Shiatsu therapy on symptoms and quality of life in patients with severe cardiac amyloidosis. It compares three targeted Shiatsu sessions with "comfort" Shiatsu and no Shiatsu, focusing on short-term impacts on neuro-cardiovascular physiological parameters and symptoms such as fatigue, sleep issues, pain, anxiety, depression, breathing difficulties, digestive problems, and nausea. The study also assesses patient satisfaction and tolerance to Shiatsu treatment. The trial is a randomized, controlled, double-blind study conducted at a single center, involving 108 patients with different types of amyloidosis (TTR, WT, AL). Participants are assigned to receive either targeted Shiatsu, comfort Shiatsu, or no Shiatsu. The study schedule includes an initial visit with questionnaires and physiological measurements, followed by Shiatsu sessions on days 7 and 14 for the Shiatsu groups, with multiple follow-up visits and telephone contacts to monitor symptoms and quality of life. Participants will complete various symptom and quality of life questionnaires and undergo physiological tests such as skin conductance (SUDOSCAN) and heart rate variability monitoring (e-patch). Follow-up assessments occur at several timepoints up to one month after the third Shiatsu session. The primary outcome is the reduction in symptom scores 48 hours after the third Shiatsu session. Secondary outcomes include improvements in physiological measures and specific symptom scales. Safety and patient satisfaction are also evaluated throughout the study.

CONDITIONS

Brief Title

Amylo-Shiatsu-Acute-Chronic: Effects of Shiatsu on Symptoms and Quality of Life of Amyloidosis Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosed with transthyretin (genetic or non-mutated) or light chain (AL) amyloidosis
  • Member or beneficiary of a social security scheme (excluding AME)
  • Provided written consent to participate
  • Score of 3 or higher on the EESE-R questionnaire for at least one symptom: dyspnea, digestive disorders, nausea, pain, anxiety, or depression
  • Overall EESE-R score of 10 or higher
Not Eligible

You will not qualify if you...

  • Orthostatic hypotension
  • Bullous amyloidosis with fragile skin
  • Previous Shiatsu treatment
  • Insufficient autonomy to maintain sitting position
  • Insufficient autonomy to travel from home to hospital
  • Participation in another interventional study, or within exclusion period of a prior study
  • Known pregnancy or breastfeeding
  • Under legal guardianship at time of inclusion
  • Beneficiary of AME (medical aid for foreigners)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Approximately 2 weeks

Participants receive three Shiatsu sessions targeted or comfort Shiatsu to evaluate effects on amyloidosis symptoms and quality of life.

3 Shiatsu sessions with assessments around each session

Follow-up

Duration - Up to 31 days after first Shiatsu session

Participants complete questionnaires and undergo physiological measurements to assess symptom changes and therapy tolerance after the Shiatsu sessions.

Multiple visits and telephone follow-ups over 31 days

Trial Site Locations

Total: 1 location

1

Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR

Créteil, France, 94010

Actively Recruiting

Loading map...

Research Team

J

JULIE POMPOUGNAC, Dr

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus ...

Cardiac Amyloidosis

Actively Recruiting

1 location

A Multi-center Registry for Clinical Information and 99mTc-p...

Heart Failure

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here